Read + Share
Kawahara T, Kawai K, Kojima T, Nagumo Y, et al. Phase II trial of nivolumab monotherapy and biomarker screening in patients with
chemo-refractory germ cell tumors. Int J Urol 2022 Apr 23. doi: 10.1111/iju.14885.
PMID: 35462438
|
 |
|
Kawahara T, Kawai K, Kojima T, Nagumo Y, et al. Phase II trial of nivolumab monotherapy and biomarker screening in patients with
chemo-refractory germ cell tumors. Int J Urol 2022 Apr 23. doi: 10.1111/iju.14885.
PMID: 35462438
|
|
|
|